Key result
Long noncoding RNAs play a key role in the regulation of immunological functions and autoimmunity, emerging as important regulators of gene expression in various autoimmune diseases.
Why the study?
The pathogenesis of autoimmune diseases is extremely complicated and has not yet been fully elucidated, while emerging evidence shows lncRNAs play a key role in immunological functions and autoimmunity.
This review highlights the emerging role of long noncoding RNAs in the pathogenesis, diagnosis, and potential treatment of autoimmune diseases.
LncRNA modulation remains investigational in autoimmunity; leaves open diagnostic and therapeutic applications pending clinical trials.
Autoimmune diseases are a group of heterogeneous disorders characterized by damage to various organs caused by abnormal innate and adaptive immune responses. The pathogenesis of autoimmune diseases is extremely complicated and has not yet been fully elucidated. Long noncoding RNAs (lncRNAs), which are defined as transcripts containing more than 200 nucleotides with no protein-coding capacity, are emerging as important regulators of gene expression via epigenetic modification, transcriptional regulation and posttranscriptional regulation. Accumulating evidence has demonstrated that lncRNAs play a key role in the regulation of immunological functions and autoimmunity. In this review, we discuss various molecular mechanisms by which lncRNAs regulate gene expression and recent findings regarding the involvement of lncRNAs in many human autoimmune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), idiopathic inflammatory myopathy (IIM), systemic sclerosis (SSc) and Sjögren's syndrome (pSS).
No takes yet. Share an insight, caveat, or question.
Zou et al. (2020) conducted a review in Autoimmune diseases. Long noncoding RNAs (lncRNAs) was evaluated. Long noncoding RNAs play a key role in the regulation of immunological functions and autoimmunity, emerging as important regulators of gene expression in various autoimmune diseases.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: